06 December 2020
Effective healthcare regulation that ensures quality treatment with easy access at an affordable price is notoriously difficult to achieve and is further complicated by the direct involvement of human life and wellbeing. The rapid development of the healthcare sector over the last decade, driven by government and private funding, has certainly put regional healthcare provision on the global map. Now, with the sector gradually maturing, it is key for existing healthcare players and new entrants to align their business model to today’s regulatory changes and shifting market conditions.
Developments in healthcare regulation in the UAE are driven by multiple factors including the government’s prioritization of the healthcare sector for the delivery of world-class care to its population; also the UAE is set to be a primary hub for medical tourism which aligns with the UAE’s and the region’s efforts for economic diversification. This, compounded by the increased mobility of medical and healthcare professionals in and out of the country and the changing face of healthcare delivery services require agile, adaptive, and effective regulatory models that ensure patient and public safety while allowing for the sector’s sustainable funding, growth, and development.
12:15 – 12:30
|A Role Model for Innovative Regulation: Where We Are and What’s Next|
Dr. Humayun Chaudhry | USA
Dr. Humayun Chaudhry | USADO, MS, MACP, MACOI President and CEO, Federation of State Medical Boards, Euless, Texas
Dr. Humayun J. Chaudhry is President and CEO of the Federation of State Medical Boards (U.S.) and Secretary of the International Association of Medical Regulatory Authorities, which he chaired from 2016 to 2018. He is a graduate of New York University, New York Institute of Technology and Harvard University. He trained in Internal Medicine at NYU-Winthrop Hospital, New York, and then served as a hospital DIO and then Assistant Dean and Chair of Medicine at NYIT. He became Health Commissioner for Suffolk County, New York, in 2007 and then FSMB’s Chief Executive in 2009. The FSMB co-owns the United States Medical Licensing Examination (USMLE) and its member boards license more than one million physicians in the United States. Dr. Chaudhry is the co-author of two books and more than 60 peer-reviewed articles.
12:30 – 12:45
|Regulations on Cancer Research|
Dr. Zisis Kozlakidis | United Kingdom
Dr. Zisis Kozlakidis | United KingdomHead, Laboratory Services and Biobank Group World Health Organization, International Agency for Research on Cancer
Dr Zisis Kozlakidis is the Head of Laboratory Services and Biobanking at the International Agency for Research on Cancer (IARC/WHO). He is responsible for one of the largest and most varied international collections of clinical samples in the world, focusing on gene–environment interactions and disease-based collections. This WHO infrastructure supports multinational efforts in making treatments possible and delivering those to resource-restricted settings.Dr. Kozlakidis has significant expertise in the field of biobanking and has served as President of ISBER. Dr. Kozlakidis is a virologist, with a PhD in microbiology from Imperial College London. He is an elected Fellow of the Linnean Society of London, the Royal Academy of Sciences, UK, and a Turnberg Fellow of the UK Academy of Medical Sciences. Dr Kozlakidis has contributed to seminal studies in the adoption of innovations into routine healthcare, and their associated financial impacts. He is scientific advisor to the PTEN Research Foundation, holds an MBA from Cass Business School, City University, London, and he is a co-founder of the City Healthcare Innovation Network, a conduit for providing and strengthening contacts between healthcare start-ups and financial institutions based in the financial district of London.
12:45 – 13:00
|Regulating Telehealth Medicine|
Dr. Robin Ohannessian | France
Dr. Robin Ohannessian | FranceMedical Director and Co-founder Telemedicine 360
Dr. Robin Ohannessian, MD MPH, is a medical doctor specialized in public health from Paris, France. He is the director of Télémédecine 360, a dedicated consulting agency for telemedicine, telehealth and digital health, created in 2015, currently advising Ministries of Health and international organizations such as the United Nations. He is also an academic researcher on telemedicine applied to neurology and stroke and board member of the French Society of Digital Health. Dr. Robin Ohannessian has conducted several works on telemedicine policies and, most recently, has published a global call to action for telemedicine integration in pandemic response for COVID-19.
13:00 – 13:15
|Regulating Information: Fighting COVID19 Infodemic|
Dr. Benjamin Hanson | United Arab Emirates
Dr. Benjamin Hanson | United Arab EmiratesMedical Director and Family Medicine Consultant, Rivers International Management Consultants
Dr Ben Hanson has extensive clinical and senior healthcare management, digital transformation and innovation management experience in Australia, Saudi Arabia and UAE. He is a Certified International Healthcare CIO (CHCIO) by the College of Healthcare Information Management Executive (CHIME) and a Certified Health Informatician Australasia and a Fellow of the Australian Institute of Digital Health (AIDH). He is a Member of the Australian Institute of Company Directors (AICD). He has Artificial Intelligence and Machine Learning qualifications from Oxford University and MIT. He is a licensed Physician in Australia and at FEMICLINIC in Dubai Healthcare City, with over 26 years direct clinical experience in high quality clinical care of patients, and an experienced educator and mentor of students and junior clinicians and colleagues. He also has 20 years of experience as a Managing Director and healthcare facility owner in Australia. He is a Fellow of the Royal Society of Medicine UK and a Fellow of the RACGP. In 2016 he was the Founding Medical Director for Meraas Healthcare, a private holding company of the Ruler of Dubai and Vice President of UAE Sheikh Mohammed bin Rashid al Maktoum. Dr Ben has been the CEO and CIO of Rivers International Management Services since 2017, with clients throughout Australia, MENA region, UK and Asia. Significant achievements in this role include as the Founding Senior Vice President of Clinical Alliance at the Abu Dhabi Health Data Services (MALAFFI), a PPP of the Department of Health Abu Dhabi and Mubadala. This initiative is the foundation of digital transformation and value-based healthcare in Abu Dhabi, with an Emirate-wide Health Information Exchange connecting all healthcare providers and patients as the core, and digital health platform including AI and ML powered analytics for advanced public and population health initiatives and chronic disease management. In 2018 with the MBF Group he was acting as Chief Operating Officer and Chief Medical Officer and lead executive in ICT and health informatics to establish 4 new hospitals with 500 beds in the Emirate of Dubai. These facilities were being developed in partnership with NHS International and The Christie from UK, and HCG from India. He was also recently the Founding Clinical Director for the innovative Abu Dhabi Stem Cells Center, owned by the Abu Dhabi Royal family. Their recent work with stem cell technology in the fight against covid19 has been remarkable and has earned international recognition and praise from the Crown Prince of the UAE.
13:15 – 13:25
|Challenge the Experts|
13:25 – 13:40
|The Integration of Aeromedicine in the UAE COVID19 Response|
Dr. Nabila Awadhi | United Arab Emirates
Dr. Nabila Awadhi | United Arab EmiratesHead Aeromedical Section, General Civil Aviation Authority
Dr.Nabila AlAwadhi is the head of Aeromedical section at General Civil Aviation Medicine. Dr Nabila is the first Aeromedical Inspector in the UAE and is recognised as the founder of the section.
13:40 – 13:55
|Futuristic Look at Reshaping Healthcare Regulations|
Mr. Martin Fletcher | Australia
Mr. Martin Fletcher | AustraliaCEO, Australian Health Practitioner Regulation Agency
Martin Fletcher is the Chief Executive Officer of the Australian Health Practitioner Regulation Agency which implements the National Registration and Accreditation Scheme regulating more than 790,000 health practitioners in partnership with 15 National Health Practitioner Boards. Prior to joining AHPRA, Martin was Chief Executive of the National Patient Safety Agency in England. From 2004-2007, Martin worked with WHO to establish a global patient safety program.
13:55 – 14:10
|Medical Regulator’s Role in Cultural Safety and Health Equity|
Dr. Tebogo Kgosietsile Solomon Letlape | South Africa
Dr. Tebogo Kgosietsile Solomon Letlape | South AfricaPresident, Health Professions Council of South Africa and Chairman of IAMRA
Dr Kgosi Letlape, is currently the Chairperson of the Medical and Dental Board and the President of the Health Professions Council of South Africa. He has obtained his MBChB degree in medicine from the University of KwaZulu Natal in 1981. In 1988, he completed his FSC (OPHTH) degree in Ophthalmology at the College of Ophthalmology Medicine South Africa. In the same year he obtained his FRCS (OPHTH) degree in Ophthalmology at the University at Edinburgh.
14:10 – 14:25
|The Value of Credential Verification and Accreditation of Medical Schools|
Ms. Lisa Cover | USA
Ms. Lisa Cover | USASenior Vice President for Business Development and Operations, ECFMG|FAIMER
As Senior Vice President for Business Development and Operations,Lisa Cover is responsible for expanding ECFMG|FAIMER services, programs, and initiatives in conjunction with the enterprise’s strategic plan. Lisa provides overall leadership of signature programs including ECFMG Certification, ERAS Support Services, the Exchange Visitor Sponsorship Program, and credential verification services including the International Electronic Portfolio of International Credentials (EPIC). Ms. Cover’s expertise and experience focus on institutional strategy; new business development, both domestic and international; and operations management. Before joining ECFMG|FAIMER in 2015, she held several leadership roles over more than a decade at The Children’s Hospital of Philadelphia (CHOP), including Senior Director of International Medicine and Assistant Vice President of Planning and New Business Development. Prior to her time at CHOP, Ms. Cover held management positions at academic medical centers, including Columbia University in New York and BJC Health System in St. Louis. She also served as Senior Associate at a prominent health care consulting firm based in New York City. Ms. Cover holds a Bachelor of Applied Arts with emphases in public health and management from Central Michigan University School of Public Health and a Master of Health Administration from Washington University School of Medicine. She is active in a variety of professional and civic organizations.
14:25 – 14:40
|Challenge the Experts|